Heterogeneous dopamine neurochemistry in the striatum: The fountain-drain matrix

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 1, 2006, Pages 31-43

  Rodriguez, Manuel ^a,b   Morales, Ingrid ^a   Gomez, Isabel ^a   Gonzalez, Sergio ^a   Gonzalez Hernandez, Tomas ^a   Gonzalez Mora, Jose Luis ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DOPAMINE; GAMMA BUTYROLACTONE; HALOPERIDOL; METIROSINE;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINE UPTAKE; ELECTROSTIMULATION; FOREBRAIN; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; COCAINE; CORPUS STRIATUM; DOPAMINE; ELECTRIC STIMULATION; ELECTROCHEMISTRY; HALOPERIDOL; HYDROGEN-ION CONCENTRATION; MALE; MEDIAL FOREBRAIN BUNDLE; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 33749022268     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104687     Document Type: Article

References (87)

1. Agnati LF, Bjelke B, and Fuxe K (1995) Volume versus wiring transmission in the brain: a new theoretical frame for neuropsychopharmacology. Med Res Rev 15:33-45.
2. Albin RL, Young AB, and Penney JB (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375.
3. Alexander GE and DeLong MR (1985a) Microstimulation of the primate neostriatum. I. Physiological properties of striatal microexcitable zones. J Neurophysiol 53:1401-1416.
4. Alexander GE and DeLong MR (1985b) Microstimulation of the primate neostriatum: II. Somatotopic organization of striatal microexcitable zones and their relation to neuronal response properties. J Neurophysiol 53:1417-1430.
5. Alexander GE, DeLong MR, and Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381.
6. Bannon MJ, Michaud RL, and Roth RH (1981) Mesocortical dopamine neurons: lack of autoreceptors modulating dopamine synthesis. Mol Pharmacol 19:270-275.
7. Bannon MJ, Reinhard JF Jr, Bunney EB, and Roth RH (1982) Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones. Nature (Lond) 296:444-446.
8. Benoit-Marand M, Borrelli E, and Gonon F (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. J Neurosci 21:9134-9141.
9. Braga PC, Dall'oglio G, and Fraschini F (1977) Microelectrode tip in five seconds: a new simple, rapid, inexpensive method. Electroencephalogr Clin Neurophysiol 42:840-842.
10. Cass WA and Gerhardt GA (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 176:259-263.
11. Chergui K, Suaud-Chagny MF, and Gonon F (1994) Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience 62:641-645.
12. Chinaglia G, Alvarez FJ, Probst A, and Palacios JM (1992) Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience 49:317-327.
13. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, and Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
14. Cotzias GC, Papavasiliou PS, and Gellene R (1969) Modification of Parkinsonism-chronic treatment with L-dopa. N Engl J Med 280:337-345.
15. Cramer SC, Nelles G, Benson RR, Kaplan JD, Parker RA, Kwong KK, Kennedy DN, Finklestein SP, and Rosen BR (1997) A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 28:2518-2527.
16. Dahlstroem A and Fuxe K (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system: I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol Scand 62 (Suppl 232):231-255.
17. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281-285.
18. Descarries L, Watkins KC, Garcia S, Bosler O, and Doucet G (1996) Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J Comp Neurol 375:167-186.
19. Diana M, Mereu G, Mura A, Fadda F, Passino N, and Gessa G (1991) Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats. Brain Res 566:208-211.
20. Doucet G, Descarries L, and Garcia S (1986) Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19:427-445.
21. Dugast C, Suaud-Chagny MF, and Gonon F (1994) Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry. Neuroscience 62:647-654.
22. Dunnett SB, Bjorklund A, and Lindvall O (2001) Cell therapy in Parkinson's disease: stop or go? Nat Rev Neurosci 2:365-369.
23. Fahn S (2000) The spectrum of levodopa-induced dyskinesias. Ann Neurol 47:S2-S11.
24. Falkenburger BH, Barstow KL, and Mintz IM (2001) Dendrodendritic inhibition through reversal of dopamine transport. Science (Wash DC) 293:2465-2470.
25. Fallon JH and Moore RY (1978) Catecholamine innervation of the basal forebrain: IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol 180:545-580.
26. Fu J and Lorden JF (1996) An easily constructed carbon fiber recording and micro-iontophoresis assembly. J Neurosci Methods 68:247-251.
27. Garris PA, Ciolkowski EL, Pastore P, and Wightman RM (1994) Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain. J Neurosci 14:6084-6093.
28. Garris PA and Wightman RM (1994) Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neurosci 14:442-450.
29. Gerfen CR (1992a) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133-139.
30. Gerfen CR (1992b) The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci 15:285-320.
31. Gerfen CR (2000) Molecular effects of dopamine on striatal-projection pathways. Trends Neurosci 23:S64-S70.
32. Gerfen CR, Baimbridge KG, and Thibault J (1987a) The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems. J Neurosci 7:3935-3944.
33. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, and Sibley DR (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science (Wash DC) 250:1429-1432.
34. Gerfen CR, Herkenham M, and Thibault J (1987b) The neostriatal mosaic: II. Patch-and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci 7:3915-3934.
35. Goldman-Rakic PS (1982) Cytoarchitectonic heterogeneity of the primate neostriatum: subdivision into island and matrix cellular compartments. J Comp Neurol 205:398-413.
36. Gonon F (1997) Prolonged and extrasynaptic excitatory action of dopamine mediated by D1 receptors in the rat striatum in vivo. J Neurosci 17:5972-5978.
37. Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19-28.
38. Gonzalez-Hernandez T, Barroso-Chinea P, De La Cruz Muros I, Del Mar Perez-Delgado M, and Rodriguez M (2004) Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons. J Comp Neurol 479:198-215.
39. Graybiel AM (1990) Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 13:244-254.
40. Graybiel AM, Hirsch EC, and Agid YA (1987) Differences in tyrosine hydroxylaselike immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc Natl Acad Sci USA 84:303-307.
41. Graybiel AM and Moratalla R (1989) Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc Natl Acad Sci USA 86:9020-9024.
42. Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, and Langston JW (1993) Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys. Adv Neurol 60:34-39.
43. Greco PG and Garris PA (2003) In vivo interaction of cocaine with the dopamine transporter as measured by voltammetry. Eur J Pharmacol 479:117-125.
44. Groves PM, Martone M, Young SJ, and Armstrong DM (1988) Three-dimensional pattern of enkephalin-like immunoreactivity in the caudate nucleus of the cat. J Neurosci 8:892-900.
45. Hagell P and Brundin P (2001) Cell survival and clinical outcome following intra-striatal transplantation in Parkinson disease. J Neuropathol Exp Neurol 60:741-752.
46. Halpain S, Girault JA, and Greengard P (1990) Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature (Lond) 343:369-372.
47. Hanley JJ and Bolam JP (1997) Synaptology of the nigrostriatal projection in relation to the compartmental organization of the neostriatum in the rat. Neuroscience 81:353-370.
48. Hoistad M, Kehr J, Andbjer B, Jansson A, and Fuxe K (2000) Intracerebral infusion of H-dopamine and H-mannitol in the striatum of halothane-anaesthetized male rats: a dual-probe microdialysis study of long-distance diffusion. Eur J Neurosci 12:2505-2514.
49. Joel D and Weiner I (2000) The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96:451-474.
50. Kawagoe KT, Garris PA, Wiedemann DJ, and Wightman RM (1992) Regulation of transient dopamine concentration gradients in the microenvironment surrounding nerve terminals in the rat striatum. Neuroscience 51:55-64.
51. +-dependent mechanism. J Biol Chem 278:12070-12077.
52. Langer LF, Jimenez-Castellanos J, and Graybiel AM (1991) The substantia nigra and its relations with the striatum in the monkey. Prog Brain Res 87:81-99.
53. Lindvall O and Hagell P (2000) Clinical observations after neural transplantation in Parkinson's disease. Prog Brain Res 127:299-320.
54. May LJ, Kuhr WG, and Wightman RM (1988) Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry. J Neurochem 51:1060-1069.
55. May LJ and Wightman RM (1989) Heterogeneity of stimulated dopamine overflow within rat striatum as observed with in vivo voltammetry. Brain Res 487:311-320.
56. Meiergerd SM, Patterson TA, and Schenk JO (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 61:764-767.
57. Michael AC, Ikeda M, and Justice JB Jr (1987) Mechanisms contributing to the recovery of striatal releasable dopamine following MFB stimulation. Brain Res 421:325-335.
58. Miller GW, Gainetdinov RR, Levey AI, and Caron MG (1999) Dopamine transporters and neuronal injury. Trends Pharmacol Sci 20:424-429.
59. Mortensen OV and Amara SG (2003) Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479:159-170.
60. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, and Olanow CW (2000a) Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: problems with the current model. Ann Neurol 47:S22-S32.
61. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, Lanciego JL, Artieda J, Gonzalo N, and Olanow CW (2000b) Pathophysiology of the basal ganglia in Parkinson's disease. Trends Neurosci 23:S8-19.
62. Peters JL and Michael AC (2000) Changes in the kinetics of dopamine release and uptake have differential effects on the spatial distribution of extracellular dopamine concentration in rat striatum. J Neurochem 74:1563-1573.
63. Pirker W (2003) Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Mov Disord 18 (Suppl 7):S43-S51.
64. Poewe W and Scherfler C (2003) Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice. Mov Disord 18 (Suppl 7):S16-S21.
65. Puopolo M, Hochstetler SE, Gustincich S, Wightman RM, and Raviola E (2001) Extrasynaptic release of dopamine in a retinal neuron: activity dependence and transmitter modulation. Neuron 30:211-225.
66. Rodriguez M and Gonzalez-Hernandez T (1999) Electrophysiological and morphological evidence for a GABAergic nigrostriatal pathway. J Neurosci 19:4682-4694.
67. Rodriguez M, Gonzalez J, Sabate M, Obeso J, and Pereda E (2003a) Firing regulation in dopaminergic cells: effect of the partial degeneration of nigrostriatal system in surviving neurons. Eur J Neurosci 18:53-60.
68. Rodriguez M, Pereda E, Gonzalez J, Abdala P, and Obeso JA (2003b) How is firing activity of substantia nigra cells regulated? Relevance of pattern-code in the basal ganglia. Synapse 49:216-225.
69. Schneider JS, Rothblat DS, and DiStefano L (1994) Volume transmission of dopamine over large distances may contribute to recovery from experimental parkinsonism. Brain Res 643:86-91.
70. Schultz W (1998) Predictive reward signal of dopamine neurons. J Neurophysiol 80:1-27.
71. Sesack SR, Aoki C, and Pickel VM (1994) Ultrastructural localization of D2 receptor-like immunoreactivity in midbrain dopamine neurons and their striatal targets. J Neurosci 14:88-106.
72. Smith Y, Bevan MD, Shink E, and Bolam JP (1998) Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86:353-387.
73. Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, and Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960-974.
74. Staal RG, Mosharov EV, and Sulzer D (2004) Dopamine neurons release transmitter via a flickering fusion pore. Nat Neurosci 7:341-346.
75. Ungerstedt U (1971) Stereotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol Scand Suppl 367:1-48.
76. Venton BJ, Michael DJ, and Wightman RM (2003) Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J Neurochem 84:373-381.
77. Voorn P, Jorritsma-Byham B, Van Dijk C, and Buijs RM (1986) The dopaminergic innervation of the ventral striatum in the rat: a light- and electron-microscopical study with antibodies against dopamine. J Comp Neurol 251:84-99.
78. Walters JR and Roth RH (1972) Effect of gamma-hydroxybutyrate on dopamine and dopamine metabolites in the rat striatum. Biochem Pharmacol 21:2111-2121.
79. Walters JR, Roth RH, and Aghajanian GK (1973) Dopaminergic neurons: similar biochemical and histochemical effects of gamma-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J Pharmacol Exp Ther 186:630-639.
80. Watanabe S, Fusa K, Takada K, Aono Y, Saigusa T, Koshikawa N, and Cools AR (2005) Effects of alpha-methyl-p-tyrosine on extracellular dopamine levels in the nucleus accumbens and the dorsal striatum of freely moving rats. J Oral Sci 47:185-190.
81. Wightman RM, Amatore C, Engstrom RC, Hale PD, Kristensen EW, Kuhr WG, and May LJ (1988) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25:513-523.
82. Wightman RM and Zimmerman JB (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res Brain Res Rev 15:135-144.
83. Winkler C, Kirik D, and Bjorklund A (2005) Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci 28:86-92.
84. Wu Q, Reith ME, Walker QD, Kuhn CM, Carroll FI, and Garris PA (2002) Concurrent autoreceptor-mediated control of dopamine release and uptake during neurotransmission: an in vivo voltammetric study. J Neurosci 22:6272-6281.
85. Wu Q, Reith ME, Wightman RM, Kawagoe KT, and Garris PA (2001) Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods 112:119-133.
86. Zimmerman JB, Kennedy RT, and Wightman RM (1992) Evoked neuronal activity accompanied by transmitter release increases oxygen concentration in rat striatum in vivo but not in vitro. J Cereb Blood Flow Metab 12:629-637.
87. Zimmerman JB and Wightman RM (1991) Simultaneous electrochemical measurements of oxygen and dopamine in vivo. Anal Chem 63:24-28.